Chemistry Professor Mike Hilinski has been awarded a R35 grant from the National Institute of General Medical Services. The grant, worth $2,059,575, will advance the Hilinski Group's research on addressing unsolved challenges in catalysis and synthesis that have immediate relevance to the contemporary
practice of drug discovery, and that have the potential for broad impact as widespread platforms for new reaction discovery and/or synthetic planning.